Antiviral Therapeutics News

CHMP backs nerandomilast for IPF and PPF in EU

European Medicines Agency · idiopathic pulmonary fibrosis · 6 min

CHMP May 2026 Output: A New Era in Drug Approvals

FDA · 5 min

Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA®

2 min

Traws Pharma Advances Tivoxavir Marboxil to Human Influenza Challenge Trial, Reports Positive Ratutrelvir COVID Data

2 min